300 norte de Iglesia de Pozos, Edificio Pekin Santa Ana San José CR 10903, San José, Santa Ana
Select an option
I am a doctor
I am a sponsor
Open studies
Breast Cancer
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010) - MK 2870-010 - Merck Sharp & Dohme LLCSee more
